Derivative (7)t(7;8): The sole karyotype abnormality in acute promyelocytic leukemia with PML/RARA rearrangement identified by RT-PCR and sequence analysis
Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party
Grimwade D., Biondi A., Mozziconacci M.J., Hagemeijer A., Berger R., Neat M., et al. Characterization of acute promyelocytic leukemia cases lacking the classic t(15;17): results of the European Working Party. Blood 96 4 (2000) 1297-1308
Detection of PML-retinoic acid receptor fusion α transcripts in acute promyelocytic leukemia with trisomy 8 but without t(15;17)
Ikeda K., Sasaki K., Tasaka T., Nagai M., Kawanishi K., Takahara J., et al. Detection of PML-retinoic acid receptor fusion α transcripts in acute promyelocytic leukemia with trisomy 8 but without t(15;17). Am J Hematol 45 3 (1994) 212-216
Identification of PML/RARA rearrangement by RT-PCR and sequencing in an acute promyelocytic leukemia without t(15;17) on G-banding and FISH
Han J.Y., Kim K.E., Kim K.H., Park J.I., and Kim J.S. Identification of PML/RARA rearrangement by RT-PCR and sequencing in an acute promyelocytic leukemia without t(15;17) on G-banding and FISH. Leukemia Res 31 (2007) 239-243
Derivative (7)t(7;8)(q34;q21): a new additional cytogenetic abnormality in acute promyelocytic leukemia
Vial J.P., Mahon F.X., Pigneux A., Notz A., Lacombe F., Reiffers J., et al. Derivative (7)t(7;8)(q34;q21): a new additional cytogenetic abnormality in acute promyelocytic leukemia. Cancer Genet Cytogenet 14 (2003) 78-81
Derivative (7)t(7;8)(q34;q21): an additional chromosome aberration in acute promyelocytic leukemia-prognostic influence debated
Haimi M., Elhasid R., Weyl Ben-Arush M., Brill-Zamir R., Laeski I., and Gershoni-Baruch R. Derivative (7)t(7;8)(q34;q21): an additional chromosome aberration in acute promyelocytic leukemia-prognostic influence debated. Cancer Genet Cytogenet 153 (2004) 81-83
The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties
Grimwade D., Walker H., Oliver F., Wheatley K., Harrison C., Harrison G., et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 92 (1998) 2322-2333
The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study Group
Schoch C., Haase D., Fonatsch C., Haferlach T., Loffler H., Schlegelberger B., et al. The significance of trisomy 8 in de novo acute myeloid leukaemia: the accompanying chromosome aberrations determine the prognosis. German AML Cooperative Study Group. Br J Haematol 99 (1997) 605-611